The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
Although it did not launch any new products, Quest announced that its existing low density lipoprotein (LDL) cholesterol tests are using a new calculation that not only improves accuracy but also eliminates the patient’s need to fast before being tested. This is the first nonfasting lipid test, the company claims. September new product launches also featured several tests capable of detecting multiple targets in a single swoop, including: The Variantyx Unity genomic test that identifies small sequence changes, structural variants, trinucleotide repeat expansions and mitochondrial variants from a single DNA sample; and Bio-Rad’s ZDC Multiplex RT-PCR , research-use only assay for simultaneous screening of Zika, dengue and chikungunya arbovirus RNA from a single sample; and Explify Respiratory, a next-generation sequencing assay capable of spotting over 200 respiratory infection pathogens in a single test and maiden launch from the collaboration between ARUP Labs and IDbyDNA, Inc. Here’s a rundown of the other key diagnostic product launches from late August through the third week of September. NEWLY LAUNCHED PRODUCTS & SERVICES Company(ies) Product(s) ARUP Laboratories and IDbyDNA, Inc. Explify Respiratory, next-generation sequencing test for respiratory infections Horizon Discovery Expansion of its functional genomic screening portfolio to include CRISPRi (interference) and CRISPRa (activation) […]
Although it did not launch any new products, Quest announced that its existing low density lipoprotein (LDL) cholesterol tests are using a new calculation that not only improves accuracy but also eliminates the patient's need to fast before being tested. This is the first nonfasting lipid test, the company claims.
September new product launches also featured several tests capable of detecting multiple targets in a single swoop, including:
- The Variantyx Unity genomic test that identifies small sequence changes, structural variants, trinucleotide repeat expansions and mitochondrial variants from a single DNA sample; and
- Bio-Rad's ZDC Multiplex RT-PCR , research-use only assay for simultaneous screening of Zika, dengue and chikungunya arbovirus RNA from a single sample; and
- Explify Respiratory, a next-generation sequencing assay capable of spotting over 200 respiratory infection pathogens in a single test and maiden launch from the collaboration between ARUP Labs and IDbyDNA, Inc.
Here's a rundown of the other key diagnostic product launches from late August through the third week of September.
NEWLY LAUNCHED PRODUCTS & SERVICES
Company(ies) | Product(s) |
ARUP Laboratories and IDbyDNA, Inc. | Explify Respiratory, next-generation sequencing test for respiratory infections |
Horizon Discovery | Expansion of its functional genomic screening portfolio to include CRISPRi (interference) and CRISPRa (activation) screening |
Qnostics | ME Evaluation Panel for meningitis/encephalitis |
Phosphorus | Test for genetic conditions associated with vision loss and blindness |
Phosphorus | Pharmacogenomic test assessing efficacy of various drugs based on genetic makeup |
BC Platforms | BC|RQUEST, a system for analyzing aggregated genomic and clinical data from multiple biobanks |
Variantyx | Variantyx Unity, test identifying small sequence changes, structural variants, trinucleotide repeat expansions and mitochondrial variants from single DNA sample |
DiaSorin Molecular | Simplexa C. difficile Direct Assay for detecting infection from C. difficile toxin B gene in liquid or unformed stool samples |
Bio-Rad Laboratories | ZDC Multiplex RT-PCR , research-use only assay for simultaneous screening of Zika, dengue and chikungunya arbovirus RNAs from single sample |
Becton Dickinson | BD Rhapsody, platform for single cell RNA analysis |
Tecan | Resolvex A200, positive pressure workstation for LC-MS sample prep |
Quest Diagnostics | New version of its LDL cholesterol test that improves accuracy and eliminates patient's need to fast before testing |
Eurofins Genoma | GeneSafe, non-invasive prenatal test that screens for both de novo and inherited single-gene disorders |
Myriad Genetics | riskScore, for measuring a woman's risk of breast cancer via algorithm combining analysis of 80 SNPs and personal and family cancer history |
Ranomics | VariantFind, DNA libraries creation platform |
Intermountain Precision Genomics Core Laboratory | RxMatch, new service enabling physicians to implement personalized medicine when prescribing medications |
Biocept | Target Selector liqud biopsy assay for mutations in NRAS oncogene |
Thermo Fisher | Ion AmpliSeq Immune Repertoire Assay Plus, TCR Beta, research-use-only sequencing panel for immuno-oncology |
Thermo Fisher | Ion Torrent Oncomine Lung Cell-Free Total Nucleic Acid Research Assay |
Cynvenio Biosystems | PD-L2 expression test, research-use-only test that measures PD-L2 expression in circulating tumor cells from a simple blood draw |
Cynvenio Biosystems | ClearID HER2 Expression, liquid biopsy test allowing for real-time monitoring of HER2 levels using a normal blood draw |
Sunquest Information Systems | Sunquest Mitogen, laboratory information management system and genetic analysis software platform |
Natera | Signatera, research-use-only circulating tumor DNA test |
Subscribe to view Essential
Start a Free Trial for immediate access to this article